Active-ingredient Dossier

Pazopanib Hydrochloride

Active-ingredient Dossier for Pazopanib Hydrochloride (tyrosine kinase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…

Brand: PAZOPANIB ADVZ
Brand: PAZOPANIB DR. REDDY'S
Brand: PAZOPANIB-RZ
Brand: VOTRIENT
Therapeutic area: Oncology

What is

Pazopanib Hydrochloride Pazopanib Hydrochloride is a tyrosine kinase inhibitor.

Australian brands containing

Pazopanib Hydrochloride — VOTRIENT — PAZOPANIB ADVZ — PAZOPANIB DR. REDDY'S — PAZOPANIB-RZ

Therapeutic areas

Pazopanib Hydrochloride is registered in oncology, with four brands available in this therapeutic area.

Sponsor landscape

Three sponsors market pazopanib hydrochloride in Australia: Dr Reddys Laboratories, Boucher & Muir, and Novartis Pharmaceuticals.

PBS and regulatory activity

One brand containing pazopanib hydrochloride is listed on the PBS, with the latest schedule date of 1 May 2026. The latest PBAC outcome is 1 July 2013 and the latest AusPAR is 22 June 2010.